Related Experiment Videos
[Thymostimulin immunoprophylaxis in elective abdominal surgery]
F Perotti1, G Landi, F Primatesta
1Divisione di Chirurgia Generale, USSL 54 Borgomanero, Novara.
Minerva Chirurgica
|June 30, 1992
Summary
This study found that Thymostimulin treatment significantly reduced postoperative infections in anergic patients undergoing abdominal surgery. Correcting immune deficiencies before operations is crucial for better patient outcomes.
Area of Science:
- Immunology
- Surgical Oncology
- Clinical Medicine
Background:
- Patients undergoing elective abdominal surgery often have pre-existing immunological deficits, classified as anergic.
- Anergic patients may face a higher risk of postoperative complications, including infections.
Purpose of the Study:
- To evaluate the efficacy of Thymostimulin in reducing postoperative infection incidence in anergic patients.
- To highlight the importance of assessing and correcting immunological status before surgery.
Main Methods:
- A cohort of 121 patients with anergic immune status undergoing elective abdominal operations was studied.
- 61 anergic patients received Thymostimulin treatment, while a control group (not explicitly detailed but implied) did not.
Main Results:
- A notable reduction in postoperative infection incidence was observed in the 61 anergic patients treated with Thymostimulin.
- The treatment demonstrated a positive impact on infection rates in this specific patient group.
Conclusions:
- Thymostimulin treatment can effectively decrease postoperative infections in anergic patients.
- Preoperative evaluation and correction of immunological alterations are vital for optimizing surgical patient care and reducing infection risk.